Intravenous epinephrine in asthma? A word of caution

Annals of Emergency Medicine

Volumn 41, Issue 5, 2003, Pages 712-713

  Green, Steven M ^a  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN;

ASTHMA; DRUG SAFETY; EMERGENCY TREATMENT; FATALITY; HUMAN; LOW DRUG DOSE; NOTE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

EID: 0037408405     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2003.145     Document Type: Note

References (7)

1. Browne GJ, Penna AS, Phung X, et al. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet. 1997;349:301-305.
2. Browne GJ, Trieu L, Van Asperen P. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department. CritCare Med. 2002;30:448-453.
3. Stephanopoulos DE, Monge R, Schell KH, et al. Continuous intravenous terhutaline for pediatric status asthmaticus. Crit Care Med. 1998;26:1744-1748.
4. Karch SB. Coronary artery spasm induced by intravenous epinephrine overdose. Am J Emerg Med. 1989;7:485-488.
5. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30:1144-1150.
6. Smith D, Riel J, Tilles I, et al. Intravenous epinephrine in life-threatening asthma. Ann Emerg Med. 2003;41:706-711.
7. Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right? JAMA. 1983;249:1743-1745.